Tim Kottke

1.7k citations

39 papers · 1.3k indexed · h-index 20

Immunology top 5%
- Mast cells and histamine 13
- Immunotherapy and Immune Responses 11
Genetics top 5%
- Virus-based gene therapy research 13
Oncology top 10%
- CAR-T cell therapy research 8
Sensory Systems top 5%
Molecular Biology
- Chemical Synthesis and Analysis 8
- Receptor Mechanisms and Signaling 7
Organic Chemistry
- Click Chemistry and Applications 4
Biotechnology
- Cancer Research and Treatments 4

Co-authors: Holger Stark Kerstin Sander Richard G. Vile Lilia Weizel Alan Melcher Jill Thompson Kevin J. Harrington Roland Seifert
Cited by: Immunology Genetics Oncology
Journals: Molecular Therapy (5 papers)Inflammation Research (3 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)
Partner nations: United States Germany United Kingdom

In The Last Decade

Tim Kottke

39 papers receiving 1.2k citations

Peers

Countries citing papers authored by Tim Kottke

Since Specialization

Citations

This map shows the geographic impact of Tim Kottke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Kottke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Kottke more than expected).

Fields of papers citing papers by Tim Kottke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Kottke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Kottke. The network helps show where Tim Kottke may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Tim Kottke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tim Kottke Line = papers co-authored together Tim Kottke links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Vesicular Stomatitis Virus Encoding a Destabilized Tumor Antigen Improves Activation of Anti-tumor T Cell Responses Molecular Therapy ·Amanda L. Huff,Laura Evgin,Jill Thompson,Tim Kottke,Christopher B. Driscoll,Jason M. Tonne,Phonphimon Wongthida,Matthew Schuelke,Kevin G. Shim,Georges Mer,Marina Ramı́rez-Alvarado,Richard G. Vile	2020	5
2	Oncolytic virus-derived type I interferon restricts CAR T cell therapy Nature Communications ·Laura Evgin,Amanda L. Huff,Phonphimon Wongthida,Jill Thompson,Tim Kottke,Jason M. Tonne,Matthew Schuelke,Katayoun Ayasoufi,Christopher B. Driscoll,Kevin G. Shim,Patrick Mackowiak,Dileep D. Monie,Aaron J. Johnson,Matt Coffey,Sarah L. Young,Gary E. Archer,John H. Sampson,José S. Pulido,Camila García Gómez,Richard G. Vile	2020	92
3	Inhibitory Receptors Induced by VSV Viroimmunotherapy Are Not Necessarily Targets for Improving Treatment Efficacy Molecular Therapy ·Kevin G. Shim,Shane Zaidi,Jill Thompson,Tim Kottke,Laura Evgin,Karishma Rajani,Matthew Schuelke,Christopher B. Driscoll,Amanda L. Huff,José S. Pulido,Richard G. Vile	2017	19
4	Synthesis, Molecular Properties Estimations, and Dual Dopamine D2 and D3 Receptor Activities of Benzothiazole-Based Ligands Frontiers in Chemistry ·Luitpold Dussler,Bassem Sadek,Tim Kottke,Lilia Weizel,Holger Stark	2017	12
5	Immunogenicity of self tumor associated proteins is enhanced through protein truncation Molecular Therapy — Oncolytics ·Tim Kottke,Kevin G. Shim,Vanesa Alonso-Camino,Shane Zaidi,Rosa María Díaz,José S. Pulido,Jill Thompson,Karishma Rajani,Laura Evgin,Elizabeth J. Ilett,Hardev Pandha,Kevin J. Harrington,Peter J. Selby,Alan Melcher,Richard G. Vile	2016	3
6	Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy Gene Therapy ·Elizabeth J. Ilett,Tim Kottke,Jill Thompson,Karishma Rajani,S. Zaidi,Laura Evgin,Matt Coffey,Christy Ralph,J.H. Manopo,H. Pandha,Kevin J. Harrington,Peter J. Selby,Richard J. Bram,Alan Melcher,Richard G. Vile	2016	59
7	Aryl-1,3,5-triazine derivatives as histamine H4 receptor ligands European Journal of Medicinal Chemistry ·Dorota Łażewska,Małgorzata Więcek,Rocio Garcia-Retamero,Katarzyna H. Kaminska,Tim Kottke,Chrisdian Sutanto,Małgorzata Zygmunt,Tadeusz Karcz,Agnieszka Olejarz‐Maciej,Kamil Kuder,Gniewomir Latacz,Marek Grosicki,Jacek Sapa,J. Karolak‐Wojciechowska,Holger Stark,Katarzyna Kieć‐Kononowicz	2014	47
8	Mutated BRAF Emerges as a Major Effector of Recurrence in a Murine Melanoma Model After Treatment With Immunomodulatory Agents Molecular Therapy ·Shane Zaidi,Anna A. Padurets,Kevin G. Shim,Elizabeth J. Ilett,Karishma Rajani,Christopher Parrish,Nicolas Boisgerault,Tim Kottke,Jill Thompson,Esteban Celis,José S. Pulido,Peter J. Selby,Hardev Pandha,Alan Melcher,Kevin J. Harrington,Richard G. Vile	2014	11
9	Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H3/H4 receptor ligands European Journal of Pharmacology ·Tim Kottke,Kerstin Sander,Lilia Weizel,Erich Schneider,Roland Seifert,Holger Stark	2011	58
10	The histamine H4 receptor: Targeting inflammatory disorders European Journal of Pharmacology ·Miriam Walter,Tim Kottke,Holger Stark	2011	34
11	N-Alkenyl and cycloalkyl carbamates as dual acting histamine H3 and H4 receptor ligands Bioorganic & Medicinal Chemistry ·Małgorzata Więcek,Tim Kottke,Xavier Ligneau,Walter Schunack,Roland Seifert,Holger Stark,Jadwiga Handzlik,Katarzyna Kieć‐Kononowicz	2011	20
12	First Metal-Containing Histamine H ₃ Receptor Ligands Organic Letters ·Kerstin Sander,Tim Kottke,Steven H. Davis,Miriam Walter,Lilia Weizel,Claus Sneppen,Xavier Ligneau,Erich Schneider,Roland Seifert,Jean‐Charles Schwartz,Holger Stark	2010	16
13	Search for histamine H4 receptor ligands in the group of 4-methylpiperazino amide derivatives Inflammation Research ·Tadeusz Karcz,Jadwiga Handzlik,Dorota Łażewska,Tim Kottke,Roland Seifert,Katarzyna Kieć‐Kononowicz	2010	1
14	Search for novel, high affinity histamine H3 receptor ligands with fluorescent properties Inflammation Research ·Kamil Kuder,Tim Kottke,Holger Stark,Xavier Ligneau,Claus Sneppen,Roland Seifert,Katarzyna Kieć‐Kononowicz	2009	10
15	Lead identification and optimization of diaminopyrimidines as histamine H4 receptor ligands Inflammation Research ·Kerstin Sander,Tim Kottke,Ewgenij Proschak,Yusuf Tanrıkulu,Erich Schneider,Roland Seifert,Gisbert Schneider,Holger Stark	2009	7
16	Histamine H3 and H4 receptor affinity of branched 3-(1H-imidazol-4-yl)propyl N-alkylcarbamates Bioorganic & Medicinal Chemistry Letters ·Dorota Łażewska,Małgorzata Więcek,Xavier Ligneau,Tim Kottke,Lilia Weizel,Roland Seifert,Walter Schunack,Holger Stark,Katarzyna Kieć‐Kononowicz	2009	18
17	2,4-Diaminopyrimidines as histamine H4 receptor ligands—Scaffold optimization and pharmacological characterization Bioorganic & Medicinal Chemistry ·Kerstin Sander,Tim Kottke,Yusuf Tanrıkulu,Ewgenij Proschak,Lilia Weizel,Erich Schneider,Roland Seifert,Gisbert Schneider,Holger Stark	2009	63
18	The inhibition of TNF-α anti-tumoral properties by blocking antibodies promotes tumor growth in a rat model Experimental Cell Research ·Nicolas Larmonier,Dominique Cathelin,Claire B. Larmonier,Xin-qiang MA,Delphine Mérino,Nona Janikashvili,Sylvain Audia,Andrew Bateman,Jill Thompson,Tim Kottke,Thomas Härtung,Emmanuel Katsanis,Richard G. Vile,Bernard Bonnotte	2007	32
19	VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment Gene Therapy ·Jing Qiao,刘生龙,Leonor Sánchez‐Pérez,Tim Kottke,J. M. Thompson,Manuel Caruso,Rosa María Díaz,Richard G. Vile	2006	18
20	A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines Nature Medicine ·Vy Phan,Fiona Errington‐Mais,M.F.P. Rojer,Tim Kottke,Michael J. Gough,Dadyou Yahya,Annick Brandenburger,Robert W. Harbeson,Scott E. Strome,Andrew Bateman,Bernard Bonnotte,Alan Melcher,Richard G. Vile	2003	61

About Tim Kottke

Tim Kottke is a scholar working on Immunology, Genetics, Biotechnology, Sensory Systems and Genetics, having authored 39 papers that have together received 1.3k indexed citations. Recurring topics across this work include Virus-based gene therapy research (13 papers), Mast cells and histamine (13 papers), Immunotherapy and Immune Responses (11 papers), Chemical Synthesis and Analysis (8 papers), CAR-T cell therapy research (8 papers), Receptor Mechanisms and Signaling (7 papers), Click Chemistry and Applications (4 papers) and Cancer Research and Treatments (4 papers). The work is most often cited by research in Immunology (606 citations), Genetics (417 citations), Oncology (386 citations), Sensory Systems (62 citations) and Molecular Biology (662 citations). Tim Kottke has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Holger Stark, Kerstin Sander, Richard G. Vile, Lilia Weizel, Alan Melcher, Jill Thompson, Kevin J. Harrington, Roland Seifert, Erich Schneider and Rosa María Díaz. Their work appears in journals such as Molecular Therapy, Inflammation Research, Bioorganic & Medicinal Chemistry Letters, Bioorganic & Medicinal Chemistry and European Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact